Krittaecho Siripassorn

机构：Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, Istituti di Ricovero e Cura a Carattere Scientifico · ORCID：0000-0001-5771-5523

发表论文 14 篇 · 总被引 458 次 · h-index 6

代表论文

• Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection (2022 · New England Journal of Medicine · 被引 312)
• Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial (2023 · The Lancet HIV · 被引 71)
• Successful drug desensitization in patients with delayed-type allergic reactions to anti-tuberculosis drugs (2018 · International Journal of Infectious Diseases · 被引 37)
• Effectiveness of Boosted Protease Inhibitor-Based Regimens in HIV Type 1-Infected Patients Who Experienced Virological Failure with NNRTI-Based Antiretroviral Therapy in a Resource-Limited Setting (2010 · AIDS Research and Human Retroviruses · 被引 14)
• Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials (2022 · HIV Medicine · 被引 9)
• Recommendations from Thai stakeholders about protecting HIV remission (‘cure’) trial participants: report from a participatory workshop (2020 · International Health · 被引 9)